Autochthonous canine cutaneous leishmaniasis caused by Leishmania (Mundinia) martiniquensis in Thailand: First evidence with successful intralesional amphotericin B treatment and a review of animal infections worldwide Authors: Wareerat Prasitwiset, Pipat Tepouypon, Punyaporn Laungthaweephol, Sineenart Chantarachart, Nuttawadee Ngamlertwong, Chuda Chittasupho, Sahatchai Tangtrongsup, Saruda Tiwanathagorn Published: 2026 ABSTRACT Autochthonous human leishmaniasis caused by Leishmania (Mundinia) martiniquensis has been increasingly reported in Northern Thailand. However, the potential animal reservoirs for this parasite remain unidentified. Herein, we report the first documented case of canine cutaneous leishmaniasis caused by L. martiniquensis in a dog from Chiang Mai Province. The patient presented with a firm, non-ulcerative nodule (0.3 × 0.4 cm) on the concave surface of the right ear pinna. Fine-needle aspiration cytology revealed protozoan amastigotes, suggestive of Leishmania infection. The parasite was successfully isolated and cultivated in Grace’s insect medium, supplemented with 30% fetal bovine serum. Molecular confirmation was performed using nested polymerase chain reaction (nPCR), real-time quantitative PCR (qPCR), sequencing, and phylogenetic analysis of the internal transcribed spacer 1 region, which classified the isolate as Leishmania martiniquensis. Comprehensive clinical evaluations, including complete blood count, serum biochemistry, and abdominal imaging (radiography and ultrasonography), revealed no evidence of systemic involvement consistent with visceral leishmaniasis. However, persistent polycythemia and mild protein alterations were observed during follow-up. Successful clinical resolution of the cutaneous lesion was achieved after four consecutive weekly intralesional amphotericin B treatments. This report demonstrates that dogs are vulnerable to cutaneous L. martiniquensis infections. A comprehensive review of clinical manifestations of L. martiniquensis infection in animals worldwide is presented, emphasizing the need for further studies on animal infection, vector transmission, and epidemiology within a One Health framework. Introduction Leishmaniasis is a zoonotic disease caused by obligate intracellular hemoflagellate protozoans of the genus Leishmania, comprising approximately 22 species known to infect humans (Hong et al., 2020; Stephen, 2024). In addition, this protozoan parasite affects a wide range of animals, including domestic species such as dogs, horses, and cattle, as well as rodents, wild animals, birds, and reptiles (Montaner and Llobat, 2023). Leishmania spp. are primarily transmitted through the bite of infected female sand flies (Phlebotomus spp. in the Old World and Lutzomyia spp. in the New World) (Lewis, 1971). Around 35 sand fly species are proven and a further 63 are suspected vectors of human leishmaniases (Dougall et al., 2011; Mann et al., 2021; Montaner and Llobat, 2023). Alongside sand flies, however, ceratopogonid biting midges of the genus Culicoides are recently experimentally proven and field-supported vectors in several endemic areas (Ampol et al., 2024). Transmission occurs when sand flies or midges, ingest amastigote-laden macrophages from an infected host. Within the vector, the amastigotes transform into promastigotes, multiply in the midgut, and mature into infective metacyclic promastigotes that migrate to the anterior part of the midgut. During a subsequent blood meal, the vector transmits these metacyclic promastigotes to a new host. Within the host, promastigotes invade phagocytes and revert to the amastigote stage, multiplying intracellularly and forming parasitophorous vacuoles. This cycle triggers clinical leishmaniasis, whereas onward transmission occurs only when infected hosts are competent reservoirs for vector infection, and some species may act as dead-end hosts (Seblova et al., 2015; Akhoundi et al., 2016; Bates, 2018; Chanmol et al., 2019; Montaner and Llobat, 2023). Leishmaniasis manifests in three major clinical forms, i.e. cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL). CL is characterized by skin lesions, often ulcerative, on exposed areas of the body. MCL affects mucous membranes, leading to partial or complete destruction of these tissues. In its most severe form, VL affects internal organs, including the spleen, liver, lymph nodes, and bone marrow, and is characterized by fever, weight loss, and anemia (WHO, 2024). Species of Leishmania are classified into four subgenera: Leishmania, Viannia, Mundinia, and Sauroleishmania. Of these, only Leishmania, Viannia, and Mundinia are known to cause disease in humans and animals (Espinosa et al., 2018; Hong et al., 2020). Approximately 22 species within these subgenera cause human leishmaniasis, zoonotic in most cases. Globally, leishmaniasis remains an important parasitic disease, but in Thailand, the current concern centers on autochthonous infections caused mainly by L. martiniquensis and L. orientalis (Chiewchanvit et al., 2015; Leelayoova et al., 2017; Torres-Guerrero et al., 2017; Sriwongpan et al., 2021; Ruang-areerate et al., 2023). Autochthonous human cases have been increasingly recognized since 1999, particularly in Northern Thailand (Leelayoova et al., 2017; Sriwongpan et al., 2021), yet the animal hosts and local transmission dynamics of these parasites remain poorly understood. Dogs are susceptible to infection with multiple Leishmania species, particularly L. infantum, and may develop a wide spectrum of clinical manifestations ranging from subclinical infection to severe systemic disease (Saridomichelakis et al., 2025). Leishmania martiniquensis has been associated with clinical CL in a cow from Switzerland (Lobsiger et al., 2010), and in horses from Florida (Reuss et al., 2012; Menezes et al., 2019), Germany and Switzerland (Müller et al., 2009), the Czech Republic and Austria (Modrý et al., 2025), Brazil (Mendes Junior et al., 2023), and Panama (Pineda et al., 2025). Additionally, black rats (Rattus rattus) have tested positive for L. martiniquensis DNA, suggesting their potential role as reservoir hosts (Chusri et al., 2014; Sriwongpan et al., 2021). Despite these findings, critical aspects of L. martiniquensis, including its prevalence, life cycle, and zoonotic potential, remain poorly understood. Against this background, we recently identified a case of canine cutaneous leishmaniasis caused by L. martiniquensis in a dog from Chiang Mai Province, Thailand. The case was monitored for approximately one year, allowing detailed evaluation of its clinical presentation, diagnostic confirmation, clinicopathological findings, and response to therapy. We also review the global distribution and clinical manifestations of L. martiniquensis infection across different animal hosts. Materials and methods Patient signalment, history, and clinical signs The patient was a 5-year-old, castrated male French Bulldog weighing 15 kg, classified as overweight, and previously diagnosed with left hip dysplasia. According to the owner’s history, the dog had continuously resided in San Kamphaeng District, Chiang Mai Province, and had no documented travel outside Northern Thailand prior to lesion development. He was presented to the Chiang Mai University Pet Hospital (PET CMU) on November 4, 2023, with a primary complaint of a mass on the concave surface of the right ear pinna. The mass had reportedly been present for approximately 1 month with minimal growth. The dog previously had a yeast infection, diagnosed and treated at the Chiang Mai University Northern Regional Veterinary Healthcare and Learning Center (NOVEL CMU). During the clinical visit, a dermatological examination was performed, leading to the diagnosis of mild allergic dermatitis associated with yeast. Fine-needle aspiration (FNA) was used to collect a sample from the ear mass for diagnostic cytology. Leishmania spp. identification Diagnostic cytology The samples collected from the mass on the right ear pinna via FNA were smeared onto glass slides and air-dried. The slides were subsequently stained with Diff-Quik® stain, following the manufacturer’s instructions. The stained slides were examined under a light microscope with 40× and 100× (oil immersion) objective lenses to assess the cytological findings. Leishmania culture Leishmania culture was initiated from FNA samples and maintained at 26 °C in 25 ml tissue culture flasks. During primary isolation, the culture was grown in 5–10 ml volumes of Grace’s Insect Medium (Gibco™, Thermo Fisher Scientific, Waltham, MA, USA), supplemented with 30% (v/v) heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin (P/S), to support initial parasite recovery from the low-yield clinical sample. After stable growth was established, the parasites were maintained in Grace’s Insect Medium containing 20% (v/v) heat-inactivated FBS and 100 U/ml P/S for routine subculture, which was sufficient for parasite maintenance while reducing serum use during propagation. After the final subculture, the parasites were harvested, washed with sterile phosphate-buffered saline (pH 7.2–7.4), and stored at −20 °C until further use. For long-term preservation, the parasites were cryopreserved in liquid nitrogen for future studies. Molecular techniques Genomic DNA was extracted from both the FNA sample and the Leishmania culture using the Nucleospin® Blood and Nucleospin® Tissue kits (Macherey-Nagel, Düren, Germany) according to the manufacturer’s protocols. Total DNA concentration was quantified using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). The extracted genomic DNA was used as a template for nested PCR (nPCR) targeting the ITS1 region, using a previously published assay for Leishmania ITS1 detection (Carvalho Ferreira et al., 2014; Sriwongpan et al., 2021). The nucleotide sequences were edited, aligned, and trimmed using MEGA X version 10.2.6 (Kumar et al., 2018) and compared with reference sequences in the NCBI database for species identification. qPCR targeting the Leishmania ITS1 region was performed as previously published (Sukhumavasi et al., 2021), using the primer pair L.ITS1.PCM2.4.6-qF and L.ITS1.PCM2.4.6-qR. Reactions were performed in triplicate for all samples, with reference DNA from L. martiniquensis and L. orientalis as positive controls, and a no-template control as a negative control. A dissociation curve analysis was conducted to determine the melting temperature (Tm) of the qPCR products. Phylogenetic analysis For taxonomic assignment, the consensus ITS1 sequence obtained in this study was compared with reference sequences in GenBank using the nucleotide Basic Local Alignment Search Tool (BLASTn) (http://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on August 9, 2024). Phylogenetic analysis was performed by aligning the ITS1 sequence from this study with 48 sequences retrieved from GenBank, representing various hosts and geographical regions (Ampol et al., 2024). The alignment and analysis were conducted using MEGA X software (Pineda et al., 2025), employing the maximum likelihood method based on the Kimura 2-parameter model with a discrete gamma distribution (K2+G). Bootstrap values were calculated from 1000 replicates. Follow-up clinical laboratory examinations Following confirmation of CL caused by L. martiniquensis, the dog was transferred to NOVEL CMU for monitoring of the mass, additional clinical laboratory examinations, and treatment planning. An outline of the interventions performed on the patient during each visit and follow-up is provided in Fig. 1. The clinical laboratory examinations included complete blood count (CBC), serum biochemistry, abdominal radiography, and abdominal ultrasonography.Fig. 1Timeline of clinical evaluations, diagnostics, and treatment phases for a dog infected with Leishmania martiniquensis. Each color represents a specific clinical evaluation or diagnostic examination: orange denotes physical examination (PE), red denotes complete blood count (CBC), yellow denotes serum biochemistry, dark green denotes abdominal radiography, light green denotes abdominal ultrasonography, blue denotes molecular identification (ID), purple denotes diagnostic cytology, and pink denotes Leishmania culture. The four-pointed stars indicate recurrence of the nodule and initiation of the corresponding treatment phase. Timeline of clinical evaluations, diagnostics, and treatment phases for a dog infected with Leishmania martiniquensis. Each color represents a specific clinical evaluation or diagnostic examination: orange denotes physical examination (PE), red denotes complete blood count (CBC), yellow denotes serum biochemistry, dark green denotes abdominal radiography, light green denotes abdominal ultrasonography, blue denotes molecular identification (ID), purple denotes diagnostic cytology, and pink denotes Leishmania culture. The four-pointed stars indicate recurrence of the nodule and initiation of the corresponding treatment phase. CBC and serum biochemistry CBC was performed using an automated hematology analyzer (BC-5300 Vet, Mindray, Shenzhen, China), and serum biochemistry analysis was conducted using an automated chemistry analyzer (BX-3010, Sysmex Corporation, Tokyo, Japan), according to the manufacturer’s instructions. The key CBC parameters included red blood cells (RBC), hematocrit, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, white blood cells (WBC), neutrophils, lymphocytes, monocytes, eosinophils, basophils, and platelets (PLT). For serum biochemistry, the analyzed parameters included blood urea nitrogen (BUN), creatinine, alanine transaminase (ALT), alkaline phosphatase (ALP), total protein, albumin, and globulin. These examinations were conducted to assess systemic indicators of VL, including anemia, lymphocytosis, azotemia, elevated liver enzymes, and hyperglobulinemia, which are commonly observed in dogs (Boggiatto et al., 2010). Abdominal radiography and ultrasonography Abdominal radiographs were obtained with a digital radiography system, with the patient in right lateral recumbency and in ventrodorsal position. Images were captured using a Hyundai Medical X-ray system (M-18S, Hyundai, Seoul, Korea) with tube potentials of 80–90 kVp and 6.3 mAs (0.025 s). The radiographic examination focused on evaluating the overall abdominal viscera (organs commonly affected by VL) for signs of organomegaly, such as hepatomegaly or splenomegaly (Koutinas and Koutinas, 2014; Melendez-Lazo et al., 2018; Ferreira et al., 2021; Morales-Yuste et al., 2022). Abdominal ultrasonography was performed using an ultrasound machine (GE Healthcare, Milwaukee, WI, USA) equipped with a 7–12 MHz transducer probe to evaluate the echogenicity, echotexture, size, and margins of the liver, spleen, and lymph nodes. These assessments were performed to determine the presence of hepatomegaly, splenomegaly, or lymphadenopathy consistent with VL, together with radiographic observation. Treatment and follow-up therapeutic response The treatment regimen was structured into three phases (Phases 3–5 in Fig. 1), each involving targeted applications of amphotericin B via intralesional or topical routes. For intralesional administration, amphotericin B was prepared to a final concentration of 5 mg/ml in sterile distilled water, and 0.2–0.4 ml (1–2 mg) was injected into the lesion depending on lesion size and local tolerance (Goyonlo et al., 2014; Goswami et al., 2019). For topical administration, a 0.1% (w/w) amphotericin B formulation compounded in the gel base was applied three times daily by the owner. The detailed compounding procedure is available from the authors upon request. Treatment phases were scheduled with designated intervals between follow-up visits. Follow-up assessments primarily consisted of serial clinical examinations and lesion photography. Molecular diagnostics, such as nPCR on FNA samples from the lesion site, were performed when lesion sampling was clinically indicated. A detailed summary of the treatment phases and follow-up intervention schedules is presented in Fig. 1. Search strategy A comprehensive search strategy was employed to identify reports of Leishmania (Mundinia) martiniquensis infection in various animal species, including companion animals, livestock, experimental animals, and wildlife. The review focused on two main aspects: epidemiology and clinical characteristics. The literature search was conducted using scientific databases, including PubMed, Scopus, and Google Scholar, to identify relevant publications available up to March 2026. Multiple search terms and combinations were used, including “Leishmania martiniquensis” AND “animal” (OR “clinical manifestations” OR “distribution”). No exclusion criteria were applied during the initial literature search. Results Clinical presentations and clinical findings During the first visit on November 4, 2023, the mass on the concave surface of the right ear pinna was minimally progressive. It measured 0.3 × 0.4 cm, was firm upon palpation (Fig. 2A). Physical examination was otherwise unremarkable, except for the patient’s overweight status and pre-existing hip dysplasia.Fig. 2Nodular lesion on the right ear pinna and diagnostic cytology using a fine-needle aspiration (FNA), Diff-Quik® stain, 100× objective lens with immersion oil under a light microscope. A Nodule lesion on the concave surface of the right ear pinna of the dog. B Fibroblasts and fibrin were observed, indicative of granulomatous inflammation. Few extracellular Leishmania amastigotes and neutrophils were present in a red blood cell-rich background. C A protozoa-laden macrophage containing numerous Leishmania amastigotes was observed alongside a few extracellular amastigotes within a red blood cell-rich background. D Numerous extracellular Leishmania amastigotes were visible in the background, along with red blood cells, lymphocytes, macrophages, and neutrophils. Nodular lesion on the right ear pinna and diagnostic cytology using a fine-needle aspiration (FNA), Diff-Quik® stain, 100× objective lens with immersion oil under a light microscope. A Nodule lesion on the concave surface of the right ear pinna of the dog. B Fibroblasts and fibrin were observed, indicative of granulomatous inflammation. Few extracellular Leishmania amastigotes and neutrophils were present in a red blood cell-rich background. C A protozoa-laden macrophage containing numerous Leishmania amastigotes was observed alongside a few extracellular amastigotes within a red blood cell-rich background. D Numerous extracellular Leishmania amastigotes were visible in the background, along with red blood cells, lymphocytes, macrophages, and neutrophils. Cytological evaluation of the FNA samples revealed low cellularity against a background of RBCs. Moderate numbers of macrophages, both non-degenerate and degenerate neutrophils, and few lymphocytes and plasma cells were observed. Intracellular amastigote protozoa characteristic of Leishmania spp. were identified within macrophages and were also present extracellularly. These amastigotes were small (2–3 μm), displayed a basophilic nucleus and prominent kinetoplast adjacent to the nucleus, and were surrounded by moderate cytoplasm. In addition, fibroblasts and fibrin were observed, suggesting granulomatous inflammation (Fig. 2B–D). These findings strongly indicated leishmaniasis, prompting additional sample collection for culture and molecular identification to confirm the diagnosis. During the follow-up period, the patient underwent clinical laboratory evaluations, including CBC and serum biochemistry, and periodic abdominal imaging by radiography and ultrasonography, as outlined in Fig. 1. CBC results consistently demonstrated polycythemia with normocytic, normochromic erythrogram findings, whereas leukocyte and platelet parameters remained within reference intervals (Supplementary Table S1). Serum biochemistry repeatedly showed hyperproteinemia and hyperalbuminemia, with intermittent hyperglobulinemia, while abdominal radiography and ultrasonography did not reveal organ changes suggestive of visceral leishmaniasis (Fig. 3, Supplementary Table S2).Fig. 3Abdominal radiographs of the dog infected with Leishmania martiniquensis during follow-up. A, B Radiographs taken on November 23, 2023. C, D Radiographs taken on November 11, 2024. A, C Right lateral views. B, D Ventro-dorsal views. Radiographic findings revealed the liver positioned within the costal arch, with a normal gastric axis and splenic silhouette, and no evidence of radiographic abnormalities suggestive of visceral involvement. Abdominal radiographs of the dog infected with Leishmania martiniquensis during follow-up. A, B Radiographs taken on November 23, 2023. C, D Radiographs taken on November 11, 2024. A, C Right lateral views. B, D Ventro-dorsal views. Radiographic findings revealed the liver positioned within the costal arch, with a normal gastric axis and splenic silhouette, and no evidence of radiographic abnormalities suggestive of visceral involvement. Confirmation of L. martiniquensis infection Leishmania was successfully isolated and cultured from FNA samples in Grace’s insect medium supplemented with 30% FBS, which supported primary parasite recovery. The growth and morphological observations presented here were obtained from Leishmania promastigotes at subculture passage 10, thereby reflecting a stabilized culture for downstream characterization. Representative promastigotes showed the expected elongated cell body and free anterior flagellum typical of Leishmania promastigotes (Fig. 4, Supplementary Fig. S1).Fig. 4Representative morphology of Leishmania martiniquensis promastigotes recovered from the canine lesion and maintained in Grace’s insect medium. Promastigotes at subculture passage 10 showed the typical elongated body form with a free anterior flagellum, consistent with Leishmania promastigotes. A Uniformly distributed, slender spindle-shaped promastigotes with prominent flagella. B Rosette-like clustering of promastigotes, suggestive of high-density culture conditions. Representative morphology of Leishmania martiniquensis promastigotes recovered from the canine lesion and maintained in Grace’s insect medium. Promastigotes at subculture passage 10 showed the typical elongated body form with a free anterior flagellum, consistent with Leishmania promastigotes. A Uniformly distributed, slender spindle-shaped promastigotes with prominent flagella. B Rosette-like clustering of promastigotes, suggestive of high-density culture conditions. DNA extracted from cultured promastigotes in this study was analyzed using nPCR. Amplification with a primer set targeting the ITS1 region yielded an expected amplicon size of 300 bp, confirming the presence of Leishmania DNA. The specificity of the Leishmania-ITS1 qPCR assay effectively distinguished L. martiniquensis from L. orientalis based on the distinct melting temperatures (Tm) of the amplified products. The amplicon Tm for L. martiniquensis was 85.0 °C, whereas that of L. orientalis was significantly lower at 81.0 °C. Notably, the sample Tm of 84.5 °C closely aligned with the reference Tm for L. martiniquensis (85.0 °C) (Sukhumavasi et al., 2021), strongly indicating its species identity (Supplementary Fig. S2). Further molecular characterization was performed by phylogenetic analysis of ITS1 sequences using MEGA X. The ITS1-nPCR products yielded 320-bp sequences, consistent with Leishmania DNA. BLAST analysis revealed 99.35% identity with a previously reported isolate from a horse in Germany (Müller et al., 2009). This result was supported by the constructed phylogenetic tree, which classified our ITS1 sequences under L. martiniquensis, with a bootstrap support value of 100%. Maximum likelihood phylogenetic analysis of the consensus sequences obtained in this study, alongside Leishmania (Mundinia) reference sequences from GenBank, revealed that the identified sequences clustered into monophyletic clades with their corresponding conspecific references. This analysis clearly separated the L. martiniquensis and L. orientalis clusters, as shown in Fig. 5.Fig. 5Phylogenetic relationships of L. martiniquensis isolated in this study and other Leishmania spp. based on ITS1 partial sequences, constructed using the maximum likelihood method based on the Kimura 2-parameter model with a discrete gamma distribution (K2+G). The newly generated sequence is indicated in red. Leishmania infantum was used as the outgroup. Bootstrap values at the nodes were calculated from 1000 replicates. Phylogenetic relationships of L. martiniquensis isolated in this study and other Leishmania spp. based on ITS1 partial sequences, constructed using the maximum likelihood method based on the Kimura 2-parameter model with a discrete gamma distribution (K2+G). The newly generated sequence is indicated in red. Leishmania infantum was used as the outgroup. Bootstrap values at the nodes were calculated from 1000 replicates. Clinical course and therapeutic response to amphotericin B Following presentation of a 0.3 × 0.4 cm firm nodule on the concave surface of the dog’s right ear pinna (Fig. 6A) and confirmation of Leishmania infection in Phase 1, the patient entered Phase 2 (observation without treatment). Periodic follow-up monitoring, including serial lesion photographs (Fig. 6B–E), was conducted for approximately 5 months, from November 23, 2023, to April 24, 2024. During this phase, the original nodule remained largely stable. Still, by the final visit, it had decreased slightly in size while two new small nodules had developed proximally beneath the original lesion (Fig. 6E).Fig. 6Nodule lesion on the concave surface of the right ear pinna of the dog infected with Leishmania martiniquensis throughout the observation timeline. APhase 1: Case presentation, November 4, 2023. B-EPhase 2: Observation without treatment: 23.11.2023 (B); 22.12.2023 (C); 24.01.2024 (D); 24.04.2024 (E). F, GPhase 3: Intralesional treatment (×2): 1.05.2024 (F); and 8.05.2024 (G). H, IPhase 4: Topical treatment (2 months): 1.07.2024 (H); and 8.08.2024 (I). J-LPhase 5: Intralesional treatment (×4): 11.09.2024 (J); 3.10.2024 (K); and 11.11.2024 (L). Panels F, H, and J represent recurrence during Phases 3–5 before initiation of the treatment regimen for each phase. Note: In panel B, the scab on the nodule resulted from the fine-needle aspiration performed in Phase 1 for diagnostic confirmation. Nodule lesion on the concave surface of the right ear pinna of the dog infected with Leishmania martiniquensis throughout the observation timeline. APhase 1: Case presentation, November 4, 2023. B-EPhase 2: Observation without treatment: 23.11.2023 (B); 22.12.2023 (C); 24.01.2024 (D); 24.04.2024 (E). F, GPhase 3: Intralesional treatment (×2): 1.05.2024 (F); and 8.05.2024 (G). H, IPhase 4: Topical treatment (2 months): 1.07.2024 (H); and 8.08.2024 (I). J-LPhase 5: Intralesional treatment (×4): 11.09.2024 (J); 3.10.2024 (K); and 11.11.2024 (L). Panels F, H, and J represent recurrence during Phases 3–5 before initiation of the treatment regimen for each phase. Note: In panel B, the scab on the nodule resulted from the fine-needle aspiration performed in Phase 1 for diagnostic confirmation. The patient returned on May 1, 2024, with a clear recurrence of the primary nodule and four smaller adjacent nodules (Fig. 6F). Phase 3 was then initiated and consisted of two intralesional amphotericin B injections given one week apart (May 1 and May 8, 2024). Because the injections were painful and owner compliance was limited, treatment was discontinued after 2 doses. Clinical response during this short treatment period was considered inconclusive (Fig. 6G). A second recurrence was noted on July 1, 2024, with the appearance of 3–4 nodules accompanied by erythema and alopecia (Fig. 6H). Phase 4 was therefore initiated using topical amphotericin B gel, selected because both the patient and owner had difficulty tolerating repeated painful intralesional injections. The topical treatment was applied by the owner three times daily for 2 months, with follow-up on August 8, 2024. By that visit, the smaller nodules had regressed, but one nodule persisted with evidence of recurrence (Fig. 6I). On September 11, 2024, the patient returned with recurrence of a single 2-mm nodule (Fig. 6J), and Phase 5 was initiated. Weekly intralesional amphotericin B was reintroduced, with four injections administered on September 11, 18, and 25 and October 3, 2024. By the final injection, the nodule had decreased markedly in size (Fig. 6K). At the last follow-up on November 11, 2024, the lesion had regressed completely, leaving only a small scar with alopecia and evidence of hair regrowth (Fig. 6L). Clinical resolution, therefore, preceded complete documentation of parasitological clearance; follow-up molecular testing of the healed site was not performed at the same visit, and post-treatment PCR results were not consistently available to define the exact interval between visible healing and molecular negativity. A concise summary of the observation and treatment phases is provided in Table 1. In this case, complete clinical resolution was achieved only after the longer, four-dose intralesional course.Table 1Summary of treatment phases, dates, and clinical response.Table 1PhaseDatesInterventionClinical responsePhase 14.11.2023 – 11.11.2023Case presentation, fine-needle aspiration from the lesion, and diagnosisLeishmania amastigotes were observedPhase 223.11.2023 – 24.04.2024Observation without treatmentThe lesion persisted during observation and later recurredPhase 31.05.2024 and 8.05.2024Fine-needle aspiration and intralesional amphotericin B (5 mg/ml), 2 dosesPartial regression; recurrence with multiple nodules by 1 July 2024Phase 41.07.2024 – 8.08.2024Topical amphotericin B 0.1% in Orabase, three times dailySmaller nodules regressed, but one lesion persistedPhase 511.09.2024 – 3.10.2024Intralesional amphotericin B (5 mg/ml), 4 weekly doses (without fine-needle aspiration before treatment)Marked regression and complete clinical resolution by 11 November 2024; same-visit molecular clearance not documented Table 1Summary of treatment phases, dates, and clinical response.Table 1PhaseDatesInterventionClinical responsePhase 14.11.2023 – 11.11.2023Case presentation, fine-needle aspiration from the lesion, and diagnosisLeishmania amastigotes were observedPhase 223.11.2023 – 24.04.2024Observation without treatmentThe lesion persisted during observation and later recurredPhase 31.05.2024 and 8.05.2024Fine-needle aspiration and intralesional amphotericin B (5 mg/ml), 2 dosesPartial regression; recurrence with multiple nodules by 1 July 2024Phase 41.07.2024 – 8.08.2024Topical amphotericin B 0.1% in Orabase, three times dailySmaller nodules regressed, but one lesion persistedPhase 511.09.2024 – 3.10.2024Intralesional amphotericin B (5 mg/ml), 4 weekly doses (without fine-needle aspiration before treatment)Marked regression and complete clinical resolution by 11 November 2024; same-visit molecular clearance not documented Summary of treatment phases, dates, and clinical response. Discussion This study presents the first documented case of canine cutaneous leishmaniasis caused by L. (M.) martiniquensis in Thailand and, to our knowledge, worldwide. This finding broadens the recognized host range of this emerging parasite and highlights its veterinary significance. Although natural infections have previously been reported in horses and cattle (Müller et al., 2009; Lobsiger et al., 2010; Reuss et al., 2012; Menezes et al., 2019; Mendes Junior et al., 2023; Modrý et al., 2025; Pineda et al., 2025), the occurrence of disease in a dog underscores the limited understanding of L. martiniquensis infection in companion animals and the scarcity of veterinary reports on this pathogen. In Thailand, L. martiniquensis is recognized as an autochthonous human pathogen (Maharom et al., 2008; Leelayoova et al., 2017; Sriwongpan et al., 2021; Ruang-areerate et al., 2023), and its DNA has been detected in black rats (Chusri et al., 2014; Sriwongpan et al., 2021). Serological evidence of Leishmania exposure has also been reported in several domestic animal species, including buffaloes, cattle, cats, and dogs, as demonstrated by seropositivity using the direct agglutination test (DAT; anti-L. donovani) or enzyme-linked immunosorbent assay (ELISA; anti-L. martiniquensis crude soluble antigen) (Sukmee et al., 2008; Chusri et al., 2014; Junsiri et al., 2017; Sriwongpan et al., 2021). In this case, serological evidence of L. martiniquensis infection was obtained, with antibodies detected by indirect ELISA (unpublished results). Collectively, these findings support the existence of an active local transmission cycle and suggest that multiple animal species may act as potential reservoir or incidental hosts. The culture comparison included in this report is intended primarily to document successful isolation and in vitro propagation of the canine-derived parasite for future phenotypic and comparative studies. Relative to the conditions reported by Siripattanapipong et al. (2019), our modified culture system used a higher FBS concentration but a lower medium volume. Although exponential growth began earlier, the peak parasite density was lower and was followed by a sharper decline. A plausible explanation is that the reduced medium volume accelerated nutrient depletion and waste accumulation despite the higher serum concentration. It is also possible that the 30% FBS condition altered medium osmolality or other physicochemical properties in a way that was only partially favorable, or even mildly inhibitory, for this isolate, despite supporting primary recovery. Whether the lower peak density also reflects an intrinsic biological feature or a unique metabolic requirement of this canine isolate cannot be determined from a single comparison. These observations indicate that cultivation protocols for L. martiniquensis still require optimization and that culture conditions should be considered when comparing growth kinetics across isolates. Molecular techniques offer highly sensitive tools for identifying Leishmania parasites, particularly in unusual hosts or samples with low organism burden (Tiwananthagorn et al., 2017; Castelli et al., 2021). In the present case, ITS1 nPCR, qPCR melt-curve analysis, sequencing, and phylogenetic reconstruction yielded concordant results supporting species identification as L. martiniquensis. Although cytology was diagnostic here, the aspirate was of low cellularity, underscoring that conventional cytology may be non-diagnostic or falsely reassuring in low-burden lesions. This is an important practical point for clinicians evaluating suspected Mundinia infections, for which culture and molecular confirmation can substantially improve diagnostic confidence when amastigotes are sparse or difficult to recognize morphologically (Rihs et al., 2025). The qPCR assay using primers L.ITS1.PCM2.4.6-qF and L.ITS1.PCM2.4.6-qR effectively distinguished L. martiniquensis from L. orientalis based on melting temperature profiles (Sukhumavasi et al., 2021), further strengthening this molecular protocol for species differentiation. Phylogenetic analysis based on the ITS1 region showed that the sequence isolated from the dog (GenBank: PQ644300) clustered closely with an L. martiniquensis isolate from a horse in Germany (GenBank: GQ281280) (Müller et al., 2009). Direct pairwise comparison with published human isolates from Chiang Mai was not possible because comparable ITS1 sequence data are not yet available from those reports. Still, the species assignment is epidemiologically consistent with human autochthonous infection in northern Thailand (Maharom et al., 2008; Chiewchanvit et al., 2015; Leelayoova et al., 2017; Sriwongpan et al., 2021; Ruang-areerate et al., 2023). This finding supports the interpretation that the canine isolate arose within the same local transmission setting rather than representing an imported infection. Equine infections are often characterized by localized nodular skin lesions that may regress without systemic disease (Müller et al., 2009; Reuss et al., 2012; Menezes et al., 2019; Mendes Junior et al., 2023; Modrý et al., 2025; Pineda et al., 2025), whereas the present dog developed recurrence after a prolonged observation period. This difference may reflect host-specific immune responses, strain-level variation, or simply the limited inference possible from a single canine case. Accordingly, the present observation should be regarded as hypothesis-generating rather than definitive. The clinicopathologic findings also warrant cautious interpretation. Although the dog showed no imaging or clinical evidence of visceral leishmaniasis, persistent increases in RBC count, hematocrit, and hemoglobin, together with repeated hyperproteinemia and hyperalbuminemia, and intermittent hyperglobulinemia, indicate that the case cannot simply be described as having no abnormalities. Given the patient’s clinical stability and the absence of progressive findings suggestive of a myeloproliferative disorder, the erythrogram pattern is more compatible with relative polycythemia than with absolute polycythemia (Weiss et al., 2010; Latimer and Duncan, 2011). Because this pattern remained stable across multiple visits, including late follow-up after marked lesion improvement, baseline individual or breed-related variation in this overweight French Bulldog cannot be excluded. French Bulldogs may also show chronically elevated hematocrit values above average, associated with brachycephalic physiology or subclinical brachycephalic obstructive airway syndrome, which can contribute to mild chronic hypoxemia; therefore, an incidental non-leishmanial explanation remains plausible in this case. Likewise, the protein profile did not follow the more typical pattern of systemic canine leishmaniasis, in which hyperglobulinemia, decreased albumin-to-globulin ratio, anemia, thrombocytopenia, and renal involvement are more prominent (Koutinas and Koutinas, 2014; Melendez-Lazo et al., 2018; Ferreira et al., 2021; Morales-Yuste et al., 2022). In this dog, the protein shifts were mild. They were dominated by persistent hyperalbuminemia, which may have reflected hydration status, chronic localized inflammation, overweight body condition, or unrelated comorbidities rather than overt systemic leishmanial involvement (Weiss et al., 2010; Latimer and Duncan, 2011; Koutinas and Koutinas, 2014; Melendez-Lazo et al., 2018; Morales-Yuste et al., 2022). Specific screening for concurrent heartworm infection or other co-infections was not available in the case record, and this should be recognized as an additional limitation when interpreting persistent hematological abnormalities in an endemic setting. Leishmaniasis in companion animals, livestock, experimental models, and wildlife ranges from asymptomatic infection to severe and potentially fatal visceral disease, with clinical manifestations varying according to parasite species and host. A comparative review of the distribution and clinical manifestations of disease caused by L. martiniquensis in various animal hosts worldwide is summarized in Table 2. Natural infections with L. martiniquensis in horses and cattle typically develop cutaneous leishmaniasis: single or multiple nodules, ulcers, crusts, papules, alopecic areas, mainly on pinnae, head, neck, legs, scrotum; lesions may be non-healing but often have a mild course and can regress spontaneously (Müller et al., 2009; Lobsiger et al., 2010; Reuss et al., 2012; Menezes et al., 2019; Mendes Junior et al., 2023; Modrý et al., 2025; Pineda et al., 2025). A recently studied horse in Panama infected with L. martiniquensis had nodular and ulcerated ear lesions without systemic involvement (Pineda et al., 2025). Cattle infected with L. martiniquensis (Switzerland) showed multiple ulcerative or plaque-like skin lesions on the muzzle, limbs, udder, and ventral abdomen; disease remained localized to the skin (Lobsiger et al., 2010; Ahmadi et al., 2024). From this review, the present case provides the first evidence of natural canine infection with L. (M.) martiniquensis causing cutaneous leishmaniasis. This observation adds dogs to the range of recognized hosts for this emerging parasite species and highlights its veterinary significance.Table 2A comprehensive review of the clinical manifestations and distribution of leishmaniasis caused by L. martiniquensis in major animal hosts worldwide.Table 2Animal & DistributionLeishmania spp.Typical clinical formKey clinical manifestationsReferenceBALB/c mouse (experimental; parasites from Thailand, Caribbean)L. martiniquensisSubclinical VLNo outward signs; transient liver and persistent spleen infection; no BM involvementSomboonpoonpol (2016); Intakhan et al. (2020); Sukhumavasi et al. (2021)Syrian golden hamster (experimental; parasites from Asia, Caribbean)L. martiniquensisProgressive VLWeight loss, cachexia, fatigue, hepatosplenomegaly, high liver/spleen/BM parasite load, severe pathology, often fatalIntakhan et al. (2020)Steppe lemming (experimental; parasites from Thailand, Australia, Caribbean)Mundinia spp. incl. L. martiniquensisCL with or without VLRange from no signs to severe ear-pinna lesions, tissue destruction, occasional weight loss; parasites in multiple organsBecvar et al. (2024)Chinese hamster (experimental; parasites from Thailand, Australia, Caribbean)Mundinia spp. incl. L. martiniquensisCL with or without VLMild to moderate skin lesions; lower burdens than in steppe lemmings; some subclinicalBecvar et al. (2024)Cattle (natural; Switzerland)L. martiniquensisCLMultiple ulcerative/plaque-like lesions on muzzle, limbs, udder, thorax, large ulcerated abdominal mass; localized skin diseaseLobsiger et al. (2010); Ahmadi et al. (2024)Horses (natural; North/Central America (United States [Florida], Panama); South America (Brazil); Europe (Germany, Switzerland, Czech Republic, Austria)L. martiniquensisCLSingle or multiple non-healing nodules/ulcers on ears, head, neck, limbs; generally mild, often spontaneously resolving; no confirmed visceral diseaseMüller et al. (2009); Reuss et al. (2012); Menezes et al. (2019); Mendes Junior et al. (2023); Ahmadi et al. (2024); Pineda et al. (2025)Abbreviations: BM, bone marrow; CL, cutaneous leishmaniasis; VL, visceral leishmaniasis. Table 2A comprehensive review of the clinical manifestations and distribution of leishmaniasis caused by L. martiniquensis in major animal hosts worldwide.Table 2Animal & DistributionLeishmania spp.Typical clinical formKey clinical manifestationsReferenceBALB/c mouse (experimental; parasites from Thailand, Caribbean)L. martiniquensisSubclinical VLNo outward signs; transient liver and persistent spleen infection; no BM involvementSomboonpoonpol (2016); Intakhan et al. (2020); Sukhumavasi et al. (2021)Syrian golden hamster (experimental; parasites from Asia, Caribbean)L. martiniquensisProgressive VLWeight loss, cachexia, fatigue, hepatosplenomegaly, high liver/spleen/BM parasite load, severe pathology, often fatalIntakhan et al. (2020)Steppe lemming (experimental; parasites from Thailand, Australia, Caribbean)Mundinia spp. incl. L. martiniquensisCL with or without VLRange from no signs to severe ear-pinna lesions, tissue destruction, occasional weight loss; parasites in multiple organsBecvar et al. (2024)Chinese hamster (experimental; parasites from Thailand, Australia, Caribbean)Mundinia spp. incl. L. martiniquensisCL with or without VLMild to moderate skin lesions; lower burdens than in steppe lemmings; some subclinicalBecvar et al. (2024)Cattle (natural; Switzerland)L. martiniquensisCLMultiple ulcerative/plaque-like lesions on muzzle, limbs, udder, thorax, large ulcerated abdominal mass; localized skin diseaseLobsiger et al. (2010); Ahmadi et al. (2024)Horses (natural; North/Central America (United States [Florida], Panama); South America (Brazil); Europe (Germany, Switzerland, Czech Republic, Austria)L. martiniquensisCLSingle or multiple non-healing nodules/ulcers on ears, head, neck, limbs; generally mild, often spontaneously resolving; no confirmed visceral diseaseMüller et al. (2009); Reuss et al. (2012); Menezes et al. (2019); Mendes Junior et al. (2023); Ahmadi et al. (2024); Pineda et al. (2025)Abbreviations: BM, bone marrow; CL, cutaneous leishmaniasis; VL, visceral leishmaniasis. A comprehensive review of the clinical manifestations and distribution of leishmaniasis caused by L. martiniquensis in major animal hosts worldwide. Abbreviations: BM, bone marrow; CL, cutaneous leishmaniasis; VL, visceral leishmaniasis. Some experimental studies in rodents and hamsters (L. martiniquensis and other Mundinia spp.) have been reported. BALB/c mice infected intraperitoneally with L. martiniquensis remained clinically asymptomatic, despite parasite DNA in liver and spleen; liver infection resolves by week 16 with no bone-marrow involvement, indicating controlled, subclinical visceralization (Somboonpoonpol, 2016; Intakhan et al., 2020; Sukhumavasi et al., 2021). Syrian golden hamsters develop progressive visceral leishmaniasis with weight loss, cachexia, fatigue, hepatosplenomegaly, high parasite burdens in liver, spleen, and bone marrow, and severe hepatic/splenic pathology, modeling chronic fatal VL (Intakhan et al., 2020). Steppe lemmings and Chinese hamsters experimentally infected intradermally with Mundinia spp. (including L. martiniquensis, L. orientalis, L. enriettii, L. macropodum, and L. chancei) show a spectrum from asymptomatic to destructive cutaneous and visceral disease; some steppe lemmings develop severe ear-pinna lesions and systemic spread, whereas others remain subclinical (Becvar et al., 2024). From an epidemiological perspective, the present case broadens the recognized host range of L. martiniquensis but does not prove that dogs function as reservoir hosts. On current evidence, the dog is more appropriately interpreted as a possible spillover host with potential epidemiological relevance. Confirmation of reservoir competence would require additional evidence, including repeated detection in dog populations, persistence of infection over time, and, critically, demonstration that infected dogs can infect competent vectors through xenodiagnosis or experimental vector-feeding studies. Environmental exposure may have contributed to the infection in this case. The dog resided in a peri-urban area and was regularly taken for walks and exercise in nearby forested environments with dense vegetation. Such habitats may provide suitable ecological conditions for potential vectors of Leishmania parasites. Although the source of infection could not be definitively determined, frequent exposure to these environments may have increased the likelihood of contact with infected vector insects. Furthermore, previous entomological studies have detected L. martiniquensis DNA in biting midges, Culicoides Latreille, in northern Thailand (Sunantaraporn et al., 2021), Culicoides peregrinus and other Culicoides spp. in southern Thailand, together with experimental transmission by ceratopogonid midges, thus supporting this possibility for L. martiniquensis (Seblova et al., 2015; Chanmol et al., 2019; Becvar et al., 2021; Kaewmee et al., 2023). This evidence suggests the circulation of this parasite in the region and supports the possibility of vector-borne transmission. These environmental and ecological observations highlight the importance of integrated surveillance involving animal hosts, vectors, and environmental risk factors to improve understanding of the epidemiology of L. martiniquensis and to support future disease prevention strategies. From a One Health perspective, veterinarians should consider L. martiniquensis in the differential diagnosis for persistent or non-healing nodular ear lesions even when systemic signs are absent. Treatment interpretation must also remain cautious. For localized cutaneous leishmaniasis, local therapies are generally favored when lesions are few and uncomplicated, whereas systemic therapy is more often reserved for larger, multiple, mucosal-risk, or immunocompromised cases (Garza-Tovar et al., 2020; Nieva et al., 2021; De Vries and Schallig, 2022). Amphotericin B was selected here because it was locally available and active against L. martiniquensis (Phumee et al., 2020). In this dog, topical amphotericin B 0.1% in the gel base, applied three times daily for two months, produced only partial regression, while the longer four-dose one-week interval intralesional course was associated with durable clinical resolution. This pattern suggests that intralesional administration may provide better local drug exposure for a small nodular lesion on the ear pinna than topical therapy alone. Still, the comparison remains confounded by the interrupted initial two-dose course, treatment-associated pain, and owner non-compliance. Because species-specific canine treatment data for L. martiniquensis are still lacking, the present case should be considered hypothesis-generating rather than protocol-defining. Following diagnosis during Phase 1, the lesion was initially small, localized, and clinically stable. Because the natural history of L. martiniquensis infection was unknown, and spontaneous regression has been reported in horses (Reuss et al., 2012; Modrý et al., 2025), the clinicians elected to monitor the lesion before initiating treatment. Therefore, this case was observed without treatment for five months. This interval may have affected disease progression and the subsequent interpretation of treatment efficacy. After Phase 5, the dog was monitored approximately every 3 months for an additional year following treatment. Follow-up evaluations included clinical examinations, hematological assessments, and molecular detection of Leishmania DNA from buffy coat samples and skin lesions when skin thickening was observed. No parasite DNA was detected during the follow-up period. However, the absence of detectable parasite DNA should be interpreted as evidence of clinical resolution rather than definitive parasitological cure, as low-level persistent infection cannot be completely excluded. This case report, therefore, has several important limitations. It describes only a single animal; post-treatment molecular follow-up was not consistently available; vector data were not collected; and broader epidemiological sampling was beyond the scope of the study. Interpretation of figure-based timelines should also be read cautiously, as lesion regression and molecular clearance were not always assessed at the same visits. In addition, treatment generalizability is constrained by the painful nature of repeated intralesional administration in tight-skinned areas such as the ear pinna and by limited regional access to antileishmanial drugs. Nevertheless, the case provides clinically useful evidence that localized canine infection with L. martiniquensis can occur in Thailand and may require prolonged local therapy when spontaneous regression does not occur. Conclusions This study presents the first documented clinical case of canine cutaneous leishmaniasis caused by L. martiniquensis in Thailand and demonstrates that dogs are vulnerable to localized infection by this parasite. This finding expands the recognized host range of this parasite in Southeast Asia. On current evidence, the dog should be interpreted conservatively as a possible spillover host with potential epidemiological relevance rather than a proven reservoir. Additional studies, including longitudinal canine surveillance, species-level molecular typing, xenodiagnosis or vector-infectivity studies, and targeted entomological investigations, are essential to clarify transmission dynamics and support evidence-based recommendations for management of this emerging zoonotic parasite. Until such data are available, veterinarians should include L. martiniquensis among the differential diagnoses for non-healing cutaneous nodules, even in dogs without overt systemic disease. Ethical approval The animal study protocol was approved by the Animal Care and Use Committee of the Faculty of Veterinary Medicine, Chiang Mai University (approval number R4/2565) in accordance with the Ethical Principles and Guidelines for the Use of Animals for Scientific Purposes, the National Research Council of Thailand. CRediT authorship contribution statement Wareerat Prasitwiset: Methodology, Formal analysis, Investigation, Data curation, Writing - original draft. Pipat Tepouypon: Methodology, Investigation, Data curation, Visualization. Punyaporn Laungthaweephol: Methodology, Investigation, Data curation, Visualization. Sineenart Chantarachart: Methodology, Validation, Investigation, Resources. Nuttawadee Ngamlertwong: Methodology, Investigation. Chuda Chittasupho: Methodology, Investigation, Resources. Sahatchai Tangtrongsup: Investigation, Writing - review & editing. Saruda Tiwanathagorn: Conceptualization, Validation, Formal analysis, Investigation, Resources, Data curation, Writing - original draft, Writing - review & editing, Visualization, Supervision, Project administration, Funding acquisition. Statement on the use of AI-assisted technologies During the preparation of this work, the authors used ChatGPT (OpenAI) to assist in improving the clarity, readability, and grammatical accuracy of the manuscript. All content generated by the tool was reviewed, revised, and verified by the authors, who take full responsibility for the integrity and accuracy of the work. Funding This research and the APC were funded by the National Research Council of Thailand (NRCT) and Chiang Mai University (N42A660374). Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.